Literature DB >> 17919623

The utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation.

Davide Ricci1, Henry D Tazelaar, Naoto Miyagi, Vinay P Rao, Rachel A Pedersen, Walter K Kremers, Guerard W Byrne, Christopher G A McGregor.   

Abstract

INTRODUCTION: Endomyocardial biopsy is the standard means of establishing cardiac allograft rejection diagnosis. The efficacy of this procedure in xenotransplantation has not been determined. In this study we compare the histology of right ventricular endomyocardial biopsy specimens with the corresponding full cross sections of explanted right ventricle (RV). We also compare RV with the related left ventricle (LV) cross sections.
METHODS: Heterotopic CD46 pig-to-baboon cardiac xenotransplants (n = 64) were studied. RV endomyocardial biopsy specimens were taken at cardiac explant by using a standard bioptome (n = 24) or by sharp dissection (n = 40). Hematoxylin and eosin stained sections of RV and LV cross-section and RV endomyocardial biopsy specimens were compared in a blinded fashion. Characteristics of delayed xenograft rejection and a global assessment of ischemia were scored from 0 to 4 according to the percentage of myocardium involved (0, 0%; 1, 1%-25%; 2, 26%-50%; 3, 51%-75%; and 4, 76%-100%).
RESULTS: Median graft survival was 30 days (range, 3-137 days). Linear regression analysis of histology scores demonstrated that specimens from both bioptome and sharp dissection equally represented the histology of the RV cross section. Global ischemic injury was strongly correlated between RV and RV endomyocardial biopsy (R(2) = 0.84) and between RV and LV cross sections (R(2) = 0.84). Individual characteristics of delayed xenograft rejection showed no significant variation between RV and RV endomyocardial biopsy or between RV and LV (p < 0.05).
CONCLUSIONS: These results indicate that delayed xenograft rejection is a widespread process involving both right and left ventricles similarly. This study shows that histologic assessment of RV endomyocardial biopsy specimens is an effective method for the monitoring of delayed xenograft rejection after cardiac xenotransplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17919623      PMCID: PMC2104516          DOI: 10.1016/j.healun.2007.07.028

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  21 in total

Review 1.  Delayed xenograft rejection.

Authors:  F H Bach; H Winkler; C Ferran; W W Hancock; S C Robson
Journal:  Immunol Today       Date:  1996-08

2.  Diagnostic reliability of endomyocardial biopsy for assessment of cardiac allograft rejection.

Authors:  T R Zerbe; V Arena
Journal:  Hum Pathol       Date:  1988-11       Impact factor: 3.466

3.  Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection.

Authors:  A G Rose; D K Cooper
Journal:  Xenotransplantation       Date:  2000-02       Impact factor: 3.907

4.  Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival.

Authors:  Guerard W Byrne; William R Davies; Keiji Oi; Vinay P Rao; Sumeet S Teotia; David Ricci; Henry D Tazelaar; Randall C Walker; John S Logan; Christopher G A McGregor
Journal:  Transplantation       Date:  2006-12-27       Impact factor: 4.939

5.  The sensitivity of transbronchial biopsy for the diagnosis of acute lung rejection.

Authors:  H D Tazelaar; F N Nilsson; M Rinaldi; P Murtaugh; J C McDougall; C G McGregor
Journal:  J Thorac Cardiovasc Surg       Date:  1993-04       Impact factor: 5.209

6.  An analysis of repeated biopsies following cardiac transplantation.

Authors:  D J Spiegelhalter; P G Stovin
Journal:  Stat Med       Date:  1983 Jan-Mar       Impact factor: 2.373

7.  Histopathology of cardiac xenograft rejection in the pig-to-baboon model.

Authors:  Martin J Goddard; JohnJ Dunning; J o Horsley; Carl Atkinson; Gilda Pino-Chavez; John Wallwork
Journal:  J Heart Lung Transplant       Date:  2002-04       Impact factor: 10.247

8.  Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys.

Authors:  Tuan T Lam; Ricardo Paniagua; Giridhar Shivaram; Henk-Jan Schuurman; Dominique C Borie; Randall E Morris
Journal:  Xenotransplantation       Date:  2004-11       Impact factor: 3.907

9.  Suppression of natural and elicited antibodies in pig-to-baboon heart transplantation using a human anti-human CD154 mAb-based regimen.

Authors:  Kenji Kuwaki; Christoph Knosalla; Frank J M F Dor; Bernd Gollackner; Yau-Lin Tseng; Stuart Houser; Nicolas Mueller; Derek Prabharasuth; Amy Alt; Kathy Moran; Jane Cheng; Amir Behdad; David H Sachs; Jay A Fishman; Henk-Jan Schuurman; Michel Awwad; David K C Cooper
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

10.  Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival.

Authors:  Johannes M Schirmer; David N Fass; Guerard W Byrne; Henry D Tazelaar; John S Logan; Christopher G A McGregor
Journal:  Xenotransplantation       Date:  2004-09       Impact factor: 3.907

View more
  2 in total

Review 1.  Update: cardiac xenotransplantation.

Authors:  Burcin Ekser; David Kc Cooper
Journal:  Curr Opin Organ Transplant       Date:  2008-10       Impact factor: 2.640

Review 2.  Porcine to Human Heart Transplantation: Is Clinical Application Now Appropriate?

Authors:  Christopher G A McGregor; Guerard W Byrne
Journal:  J Immunol Res       Date:  2017-11-07       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.